Last update 01 Nov 2024
Paladin Pharma SpA

Paladin Pharma SpA

Private Company|
1996|
Italy
|
10-50
|
www.paladinpharma.it

Overview

Tags

Immune System Diseases
Prophylactic vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Immune System Diseases1
Top 5 Drug TypeCount
Prophylactic vaccine1

Related

3
Drugs associated with Paladin Pharma SpA
Weed/MPL-containing Pollinex allergy desensitization vaccine(Paladin Pharma SpA)
Target-
Mechanism-
Active Org.
Paladin Pharma SpAPaladin Pharma SpA
Originator Org.
Paladin Pharma SpAPaladin Pharma SpA
Active Indication
Hypersensitivity
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
DE
First Approval Date01 Sep 1999
Exisulind
Target
PDE5A x cGMP-PDE
Mechanism
PDE5A inhibitors [+1]
Active Org.-
Originator Org.
OSI Pharmaceuticals, Inc.OSI Pharmaceuticals, Inc.
Active Indication-
Inactive Indication
Adenomatous Polyposis Coli [+6]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Davunetide
Target
Tubulin
Mechanism
Tubulin modulators
Active Org.-
Originator Org.
Paladin Pharma SpAPaladin Pharma SpA
Active Indication-
Inactive Indication
Cognitive Dysfunction [+3]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Paladin Pharma SpA
Login to view more data
0 Patents (Medical) associated with Paladin Pharma SpA
Login to view more data
100 Deals associated with Paladin Pharma SpA
Login to view more data
100 Translational Medicine associated with Paladin Pharma SpA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
2
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free